Approaches to the targeting of treatment for osteoporosis (Q37569551)

21 August 2017

1 reference

title

Approaches to the targeting of treatment for osteoporosis (English)

1 reference

21 August 2017

0 references

2

Eugene V McCloskey

1 reference

21 August 2017

4

Anders Oden

1 reference

21 August 2017

1

John A Kanis

1 reference

21 August 2017

3

Helena Johansson

1 reference

PubMed ID

19648943

21 August 2017

language of work or name

English

0 references

publication date

1 August 2009

1 reference

Nature Reviews Rheumatology

21 August 2017

1 reference

21 August 2017

5

1 reference

21 August 2017

8

1 reference

21 August 2017

425-431

1 reference

https://scigraph.springernature.com/pub.10.1038/nrrheum.2009.139

21 August 2017

0 references

cites work

Should perimenopausal women be screened for osteoporosis?

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.139

Should women get screening bone mass measurements?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.139

Screening for osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.139

Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.139

Long-term risk of osteoporotic fracture in Malmö.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.139

Adverse outcomes of osteoporotic fractures in the general population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.139

Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.139

A reference standard for the description of osteoporosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.139

The prevention and treatment of osteoporosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.139

The use of calcium in the management of osteoporosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.139

Therapeutic strategies in the prevention of hip fracture with drugs affecting bone metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.139

Recommendations for the application of bone density measurement. What can you believe?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.139

Ten-year risk of osteoporotic fracture and the effect of risk factors on screening strategies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.139

Screening for osteoporosis in postmenopausal women: recommendations and rationale

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.139

Official positions of the international society for clinical densitometry.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.139

Guidelines for diagnosis and management of osteoporosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.139

Diagnosis of osteoporosis and assessment of fracture risk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.139

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.139

A New Approach to the Development of Assessment Guidelines for Osteoporosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.139

The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.139

Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.139

Recommendations for bone mineral density reporting in Canada: a shift to absolute fracture risk assessment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.139

Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.139

[Diagnosis and treatment of postmenopausal osteoporosis and osteoporosis in men. German Guidelines Update 2006]

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.139

Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.139

Assessment of 10-year absolute fracture risk: a new paradigm with worldwide application

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.139

The cost-effectiveness of alendronate in the management of osteoporosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.139

Requirements for DXA for the management of osteoporosis in Europe

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.139

Ten-year fracture probability in Hong Kong Southern Chinese according to age and BMD femoral neck T-scores

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.139

Remaining lifetime and absolute 10-year probabilities of osteoporotic fracture in Swiss men and women.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.139

Cost-effective osteoporosis treatment thresholds: the United States perspective

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.139

Intervention thresholds for osteoporosis in the UK

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.139

Intervention thresholds for osteoporosis in men and women: a study based on data from Sweden

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.139

At what hip fracture risk is it cost-effective to treat? International intervention thresholds for the treatment of osteoporosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2009.139

Treatment of established osteoporosis: a systematic review and cost-utility analysis.

31 March 2020

1 reference

12 December 2020

Prevention of osteoporosis and osteoporotic fractures in postmenopausal women: recommendation statement from the Canadian Task Force on Preventive Health Care.

1 reference

12 December 2020

Bone density measurement--a systematic review. A report from SBU, the Swedish Council on Technology Assessment in Health Care

1 reference

12 December 2020

Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group

1 reference

12 December 2020

Current understanding of osteoporosis according to the position of the World Health Organization (WHO) and International Osteoporosis Foundation.

1 reference

12 December 2020

CBO guideline 'Osteoporosis' (second revision

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRRHEUM.2009.139

1 reference

21 August 2017

1 reference

PubMed ID

19648943